QP 26 - The Right Patient, the Right Treatment: Machine Learning for Stratification and Prediction

Presentations

• 05:00pm - 05:05pm ET

  Introductions

  Speaker: Jun Deng, PhD, FASTRO - Yale University, New Haven
• 05:05pm - 05:10pm ET

  Dynamic Hematologic Trajectories and Machine Learning to Predict Survival and Radiotherapy Benefit In Unresectable Esophageal Squamous Cell Carcinoma Receiving Immunotherapy: A Multicenter, Real-World Study

  Speaker: Wenbin Shen, - The Fourth Hospital of Hebei Medical University, Shijiazhuang
• 05:10pm - 05:15pm ET

  Community-Based Health System Validation of the SHIELD-RT Machine Learning Model to Prevent Acute Care Events During Radiotherapy

  Speaker: Marianna Elia, MS, BS - University of California San Francisco, San Francisco
• 05:15pm - 05:20pm ET

  Novel Counterfactual Machine Learning Reveals Treatment-Specific Radiosensitivity in Gastric Cancer

  Speaker: Julia Balmaceda, MD - Washington University, St. Louis
• 05:20pm - 05:25pm ET

  Comparing Face Photograph-Based and Blood-Based Biological Age Biomarkers for Survival Prediction in Patients Receiving Radiation Therapy

  Speaker: Fridolin Haugg, MS - Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston
• 05:20pm - 05:25pm ET

  Comparing Face Photograph-Based and Blood-Based Biological Age Biomarkers for Survival Prediction in Patients Receiving Radiation Therapy

  Speaker: Fridolin Haugg, MS - Artificial Intelligence in Medicine (AIM) Program, Mass General Brigham, Harvard Medical School, Boston
• 05:25pm - 05:30pm ET

  Spatially Informed Score of Thymic Activity and Reserve is Associated with Pathologic Complete Response to Induction Chemoimmunotherapy in Locally Advanced NSCLC

  Speaker: Elaine Yang, BS - Yale School of Medicine, New Haven
• 05:25pm - 05:30pm ET

  Spatially Informed Score of Thymic Activity and Reserve is Associated with Pathologic Complete Response to Induction Chemoimmunotherapy in Locally Advanced NSCLC

  Speaker: Elaine Yang, BS - Yale School of Medicine, New Haven
• 05:30pm - 05:35pm ET

  NIMOD: A Noninvasive Multimodality Oncology Defacer with Near-Chance Reidentification Risk and Preserved Data Utility

  Speaker: Du Wang, PhD, MS - Hospital of the University of Pennsylvania, Philadelphia
• 05:30pm - 05:35pm ET

  NIMOD: A Noninvasive Multimodality Oncology Defacer with Near-Chance Reidentification Risk and Preserved Data Utility

  Speaker: Du Wang, PhD, MS - Hospital of the University of Pennsylvania, Philadelphia
• 05:35pm - 05:55pm ET

  Questions & Answers

  Speaker: Soumyajit Roy, MBBS, MSc. - University Hospitals Seidman Cancer Center, Cleveland
• 05:55pm - 06:00pm ET

  Closing

  Speaker: Jun Deng, PhD, FASTRO - Yale University, New Haven